Apple, Kodak Discuss Patents and 4 Hot Stocks Seeing Action
OSI Systems, Inc. (NASDAQ:OSIS): In a letter to Transportation Security Administration chief John Pistole, U.S. lawmaker Mike Rogers stated that OSI Systems’ Rapiscan unit may have falsified software tests that were put in place to stop the machines from recording graphic images of travelers, Bloomberg reported yesterday. However, Peter Kant, who is an executive vice president with the company, stated in an interview that “at no time did Rapiscan falsify test data or any information related to this technology or the test.”
Dollar Tree, Inc. (NASDAQ:DLTR) sees its Q4 revenue reaching $2.2 billion to $2.26 billion, consensus $2.24 billion. The company also sees a rise in flat to low single digit SSS.
Our 20-page proprietary analysis of Apple’s stock is ready. Click here and to get your Cheat Sheet report now!
Apple Inc. (NASDAQ:AAPL): Kodak (EKDKQ) was given permission by the court to retain exclusive control of its bankruptcy case through February 28 as it hopes to execute a $793 million financing offer from bondholders, according to Reuters. The publications stated that Kodak continues to be talking with Apple and Google (NASDAQ:GOOG) for patents, and states that it is “confident” the patents will gain $500 million.
Ross Stores Inc.’s (NASDAQ:ROST) Q4 guidance range is to include the projected 8c to 9c benefit to EPS from FY12’s 53rd week.
Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): Calcalist financial daily has stated that Teva is the leading candidate for the purchase of Amarin (NASDAQ:AMRN), according to Reuters. The publication also stated that AstraZeneca (AZZN) has been considering purchasing the biopharmaceutical company. Amarin’s market value on Nasdaq totals $1.6 billion.
Don’t Miss: Apple Gets a Bigger Share of This Pie.